留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

抗疟药的剂型研究进展

刘萍,  卢光照,  鲁莹,  邹豪

downloadPDF
文章导航 > 药学实践与服务  > 2019 >  37(6): 481-484
刘萍, 卢光照, 鲁莹, 邹豪. 抗疟药的剂型研究进展[J]. 药学实践与服务, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
引用本文: 刘萍, 卢光照, 鲁莹, 邹豪. 抗疟药的剂型研究进展[J]. 药学实践与服务, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
shu
LIU Ping, LU Guangzhao, LU Ying, ZOU Hao. Advances in research on antimalarial dosage forms[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
Citation: LIU Ping, LU Guangzhao, LU Ying, ZOU Hao. Advances in research on antimalarial dosage forms[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
shu

抗疟药的剂型研究进展

doi: 10.3969/j.issn.1006-0111.2019.06.001
  • 1.

    海军军医大学药学院药剂学教研室, 上海 200433;解放军第九七〇医院药剂科, 山东 烟台 264001

  • 2.

    海军军医大学药学院药剂学教研室, 上海 200433

基金项目: 国家自然科学基金项目（81773278）；军队后勤科研重大项目（AWS14J011）；重大新药创制（2018ZX09J18110-004）

Advances in research on antimalarial dosage forms

  • 1.

    Department of Pharmaceutics, School of Pharmacy, Naval Medical University, Shanghai 200433, China;Department of Pharmacy, No. 970 hospital of PLA, Yantai 264001, China

  • 2.

    Department of Pharmaceutics, School of Pharmacy, Naval Medical University, Shanghai 200433, China

  • 摘要: 疟疾是发展中国家尤其是非洲地区所面临的传染病中的头号杀手，严重威胁人类健康。喹啉类、二氢叶酸还原酶抑制剂以及青蒿素类药物是目前治疗疟疾的主要药物，具有良好的临床应用价值，但存在溶解度差、缺乏靶向性等缺点。目前，优化抗疟疾药物剂型已成为研究的热点。现对抗疟药的各种优化剂型，例如固体分散体、环糊精包合物、纳米粒、脂质体等进行综述。
    Abstract: Malaria is a critical public health problem resulting in substantial morbidity and mortality in developing countries,especially in Africa.Quinoline,dihydrofolate reductase inhibitors and artemisinin drugs are currently the main drugs for the treatment of malaria,and have good clinical application value,but have the disadvantages of poor solubility,low bioavailability and lack of targeting.To overcome these drawbacks,optimizing the anti-malarial drug dosage form has become a research hotspot at present.Various optimized dosage forms for antimalarial drugs,such as solid dispersions,cyclodextrin inclusion complexes,nanoparticles,liposomes,etc.,are now reviewed.
  • [1] RAHMAN K,KHAN S U,FAHAD S,et al.Nano-biotechnology:a new approach to treat and prevent malaria[J].Int J Nanomedicine,2019,14:1401-1410.
    [2] SAEED M A,ANSARI M T,CH B A.Enhancement of solubility and dissolution profile of artesunate by employing solid dispersion approach:an in-vitro evaluation[J].Pak J Pharm Sci,2019,32(1):353-361.
    [3] SHAHZAD Y,SOHAIL S,ARSHAD M S,et al.Development of solid dispersions of artemisinin for transdermal delivery[J].Int J Pharm,2013,457(1):197-205.
    [4] LETCHMANAN K,SHEN S C,NG W K,et al.Enhanced dissolution and stability of artemisinin by nano-confinement in ordered mesoporous SBA-15 particles[J].J Microencapsul,2015,32(4):390-400.
    [5] KAKRAN M,SAHOO N G,LI L,et al.Dissolution enhancement of artemisinin with β-cyclodextrin[J].Chem Pharm Bull,2011,59(5):646-652.
    [6] 陈方伟,郭涛,李海燕,等.双氢青蒿素羟丙基-β-环糊精包合物的制备与表征[J].药学学报,2012,47(4):529-534.
    [7] KUMAR H,GOTHWAL A,KHAN I,et al.Galactose-anchored gelatin nanoparticles for primaquine delivery and improved pharmacokinetics:a biodegradable and safe approach for effective antiplasmodial activity against P.falciparum 3D7 and in vivo hepatocyte targeting[J].Mol Pharm,2017,14(10):3356-3369.
    [8] DAI H L,GAO W Q,ZHANG G S,et al.Preparation of the nanostructured lipid carriers of artemisinin and its pharmacokinetic evaluation[J].J Chin Pharm,2017,26(3),180-186.
    [9] WANG L,WANG Y F,WANG X Q,et al.Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity[J].J Microencapsul,2016,33(1):43-52.
    [10] DAUDA K,BUSARI Z,MORENIKEJI O,et al.Poly(D,L-lactic-co-glycolic acid)-based artesunate nanoparticles:formulation,antimalarial and toxicity assessments[J].J Zhejiang Univ Sci B,2017,18(11):977-985.
    [11] 余荧蓝,郑智元,伊宸辰,等.青蒿素长循环脂质体的制备及体外性质评价[J].药学学报,2018,53(6):1002-1008.
    [12] 史光玉,王晓蕾,王锐利,等.蒿甲醚纳米结构脂质载体的制备及体外释放[J].中国医药工业杂志,2017,48(5):699-705.
    [13] 胡诚,梁琨,安叡,等.TPGS修饰青蒿琥酯脂质体的制备及其体外抗肿瘤活性[J].中成药,2017,39(3):492-498.
    [14] 田柳.蒿甲醚脂质体的制备以及其抗肿瘤作用的研究[D].济南:山东大学,2018.
    [15] ISACCHI B,BERGONZI M C,GRAZIOSO M,et al.Artemisinin and artemisinin plus curcumin liposomal formulations:enhanced antimalarial efficacy against Plasmodium berghei-infected mice[J].Eur J Pharm Biopharm,2012,80(3):528-534.
    [16] 史光玉.胆碱-聚乙二醇双修饰蒿甲醚脂质纳米粒的制备及其体内外药效与初步靶向性研究[D].太原:山西医科大学,2017.
    [17] 柯云玲,潘金明,席建军,等.青蒿琥酯自微乳的制备与质量评价[J].医药导报,2018,37(6):735-740.
    [18] 张亚红,唐倩,刘耀,等.自微乳化给药系统提高蒿甲醚大鼠的口服生物利用度[J].第三军医大学学报,2014,36(14):1481-1485.
    [19] 席建军,张建康,潘旭旺,等.青蒿琥酯自微乳在大鼠体内的药动学研究[J].中国现代应用药学,2017,34(3):385-389.
    [20] 田霞,范云周,孙媛,等.星点设计-效应面法优化蒿甲醚自微乳释药系统[J].国际药学研究杂志,2016,43(5):966-970.
    [21] 沈雪松,莫宇玲,金美华,等.青蒿素衍生物微乳系统的研究[J].时珍国医国药,2011,22(4):892-894.
    [22] SAHU S K,RAM A.Preparation and characterization of chloroquine loaded microspheres for prophylactic use[J].Curr Drug Deliv,2013,10(5):601-607.
    [23] 潘旭旺,庄让笑,邵益丹,等.青蒿琥酯聚乳酸微球的制备及其药剂学性质研究[J].中华中医药学刊,2014,32(7):1760-1762.
    [24] KHEIRI MANJILI H R,MALVANDI H,MOSAVI M,et al.Preparation and physicochemical characterization of biodegradable mPEG-PCL core-shell micelles for delivery of artemisinin[J].Pharm Sci,2016,22(4):234-243.
    [25] MANJILI H K,MALVANDI H,MOUSAVI M S,et al.In vitro and in vivo delivery of artemisinin loaded PCL-PEG-PCL micelles and its pharmacokinetic study[J].Artif Cells Nanomed Biotechnol,2018,46(5):926-936.
    [26] PESTEHCHIAN N,VAFAEI M R,NEMATOLAHY P,et al.A new effective antiplasmodial compound:nanoformulated pyrimethamine[J].J Glob Antimicrob Resist,2019,19:S2213-S7165.
    [27] 邱玉琴,李春,张锁慧,等.蒿甲醚可溶解微针透皮贴片的制备和评价[J].今日药学,2016,26(8):532-537.
    [28] QIU Y Q,LI C,ZHANG S H,et al.Systemic delivery of artemether by dissolving microneedles[J].Int J Pharm,2016,508(1-2):1-9.
    [29] JAIN K,SOOD S,GOWTHAMARAJAN K.Optimization of artemether-loaded NLC for intranasal delivery using central composite design[J].Drug Deliv,2015,22(7):940-954.
    [30] 葛斌,徐闫,丁俊威,等.抗疟疾新药研发的各种策略[J].国外医药抗生素分册,2018,39(1):1-13.
  • [1] 张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英.  二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
    [2] 崔亚玲, 吴琼, 马良煜, 胡北, 姚东, 许子华.  肝素钠肌醇烟酸酯乳膏中肌醇烟酸酯皮肤药动学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404006
    [3] 陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠.  UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(8): 341-345. doi: 10.12206/j.issn.2097-2024.202404082
    [4] 邹思, 吴岩斌, 吴锦忠, 吴建国, 黄家兴.  虎奶菇菌核多糖功能化纳米硒抗疲劳功效研究 . 药学实践与服务, 2024, 42(10): 426-432. doi: 10.12206/j.issn.2097-2024.202206072
    [5] 郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛.  醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  4739
  • HTML全文浏览量:  605
  • PDF下载量:  1259
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-04-08
  • 修回日期:  2019-10-28

抗疟药的剂型研究进展

doi: 10.3969/j.issn.1006-0111.2019.06.001
  • 1. 海军军医大学药学院药剂学教研室, 上海 200433;解放军第九七〇医院药剂科, 山东 烟台 264001
  • 2. 海军军医大学药学院药剂学教研室, 上海 200433
    • 基金项目:  国家自然科学基金项目（81773278）；军队后勤科研重大项目（AWS14J011）；重大新药创制（2018ZX09J18110-004）
  • 收稿日期: 2019-04-08
  • 修回日期: 2019-10-28

摘要: 疟疾是发展中国家尤其是非洲地区所面临的传染病中的头号杀手，严重威胁人类健康。喹啉类、二氢叶酸还原酶抑制剂以及青蒿素类药物是目前治疗疟疾的主要药物，具有良好的临床应用价值，但存在溶解度差、缺乏靶向性等缺点。目前，优化抗疟疾药物剂型已成为研究的热点。现对抗疟药的各种优化剂型，例如固体分散体、环糊精包合物、纳米粒、脂质体等进行综述。

English Abstract

刘萍, 卢光照, 鲁莹, 邹豪. 抗疟药的剂型研究进展[J]. 药学实践与服务, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
引用本文: 刘萍, 卢光照, 鲁莹, 邹豪. 抗疟药的剂型研究进展[J]. 药学实践与服务, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
shu
LIU Ping, LU Guangzhao, LU Ying, ZOU Hao. Advances in research on antimalarial dosage forms[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
Citation: LIU Ping, LU Guangzhao, LU Ying, ZOU Hao. Advances in research on antimalarial dosage forms[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(6): 481-484. doi: 10.3969/j.issn.1006-0111.2019.06.001
shu

    全文HTML

参考文献 (30)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计